These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12476435)

  • 21. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic testing for breast and ovarian cancer: ethical, legal, and psychosocial considerations.
    Lessick M
    Nurs Womens Health; 2007 Aug; 11(4):390-9; quiz 400-1. PubMed ID: 17883756
    [No Abstract]   [Full Text] [Related]  

  • 24. Hereditary breast and ovarian cancer: research on how women respond to genetic testing.
    Bingham R
    Nurs Womens Health; 2012; 16(4):319-24. PubMed ID: 22900808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer.
    Aktan-Collan K; Haukkala A; Mecklin JP; Uutela A; Kääriäinen H
    J Med Genet; 2001 Nov; 38(11):787-92. PubMed ID: 11732490
    [No Abstract]   [Full Text] [Related]  

  • 26. Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; van Gool AR; Klijn JG; Tibben A
    Clin Genet; 2007 Jan; 71(1):35-42. PubMed ID: 17204044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.
    Shulman LP
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive testing for hereditary breast and ovarian cancer: a psychological framework for pre-test counselling.
    Decruyenaere M; Evers-Kiebooms G; Denayer L; Welkenhuysen M; Claes E; Legius E; Demyttenaere K
    Eur J Hum Genet; 2000 Feb; 8(2):130-6. PubMed ID: 10757645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Familial tumor].
    Nasu J; Ohsumi S; Masuta H; Tanimizu M
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():494-500. PubMed ID: 20976925
    [No Abstract]   [Full Text] [Related]  

  • 30. SEOM clinical guidelines for hereditary cancer.
    Graña B; Lastra E; Llort G; Brunet J; Isla D
    Clin Transl Oncol; 2011 Aug; 13(8):580-6. PubMed ID: 21821494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing.
    van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
    Ann Oncol; 2006 Jul; 17(7):1090-5. PubMed ID: 16600981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary risk of women's cancers.
    Frank TS; Critchfield GC
    Best Pract Res Clin Obstet Gynaecol; 2002 Oct; 16(5):703-13. PubMed ID: 12475549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
    Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
    Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
    Meiser B; Collins V; Warren R; Gaff C; St John DJ; Young MA; Harrop K; Brown J; Halliday J
    Clin Genet; 2004 Dec; 66(6):502-11. PubMed ID: 15521977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gynecologic manifestations of hereditary nonpolyposis colorectal cancer. From inherited to sporadic disease.
    Taylor N; Mutch DG
    Oncology (Williston Park); 2006 Jan; 20(1):85-94; discussion 94-6, 100. PubMed ID: 16572595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
    Claes E; Evers-Kiebooms G; Boogaerts A; Decruyenaere M; Denayer L; Legius E
    Am J Med Genet A; 2003 Jan; 116A(1):11-9. PubMed ID: 12476445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic counseling in hereditary nonpolyposis colorectal cancer.
    Menko FH; Wijnen JT; Khan PM; Vasen HF; Oosterwijk MH
    Oncology (Williston Park); 1996 Jan; 10(1):71-6; discussion 81-2. PubMed ID: 8924367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study.
    Aktan-Collan K; Haukkala A; Mecklin JP; Uutela A; Kääriäinen H
    Int J Cancer; 2001 Aug; 93(4):608-11. PubMed ID: 11477567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic testing set for takeoff.
    Nowak R
    Science; 1994 Jul; 265(5171):464-7. PubMed ID: 8036486
    [No Abstract]   [Full Text] [Related]  

  • 40. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
    Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
    Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.